EZH2 is a core member of the PRC2 gene silencing complex that has methyltransferase activity and catalyses histone H3K27 trimethylation and heterochromatin formation, and thereby mediates tumour suppressor gene expression silencing.23 The gene discussed is EZH2; the disease is neoplasm.